HK1089159A1 - Inhibitors of nucleoside metabolism - Google Patents
Inhibitors of nucleoside metabolismInfo
- Publication number
- HK1089159A1 HK1089159A1 HK06109456A HK06109456A HK1089159A1 HK 1089159 A1 HK1089159 A1 HK 1089159A1 HK 06109456 A HK06109456 A HK 06109456A HK 06109456 A HK06109456 A HK 06109456A HK 1089159 A1 HK1089159 A1 HK 1089159A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sub
- compounds
- halogen
- chosen
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/949,388 US5985848A (en) | 1997-10-14 | 1997-10-14 | Inhibitors of nucleoside metabolism |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1089159A1 true HK1089159A1 (en) | 2006-11-24 |
Family
ID=25489007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06109456A HK1089159A1 (en) | 1997-10-14 | 2006-08-25 | Inhibitors of nucleoside metabolism |
Country Status (14)
Country | Link |
---|---|
US (7) | US5985848A (fr) |
EP (1) | EP1023308B1 (fr) |
JP (1) | JP4451983B2 (fr) |
KR (1) | KR100637479B1 (fr) |
CN (2) | CN1220695C (fr) |
AT (1) | ATE304019T1 (fr) |
AU (1) | AU749098B2 (fr) |
CA (1) | CA2305760C (fr) |
DE (1) | DE69831499T2 (fr) |
DK (1) | DK1023308T3 (fr) |
ES (1) | ES2249844T3 (fr) |
HK (1) | HK1089159A1 (fr) |
PT (1) | PT1023308E (fr) |
WO (1) | WO1999019338A1 (fr) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985848A (en) * | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
FR2790915B1 (fr) * | 1999-03-19 | 2001-06-01 | Commissariat Energie Atomique | Procede de criblage et de selection d'antiparasitaires apicomplexes et/ou d'herbicides et ses applications |
ES2625636T3 (es) * | 1999-04-08 | 2017-07-20 | Victoria Link Limited | Proceso para preparar inhibidores del metabolismo de nucleósidos |
WO2001019375A1 (fr) | 1999-09-15 | 2001-03-22 | Biocryst Pharmaceuticals, Inc. | Procede permettant d'inhiber la proliferation d'un lymphocyte t |
US6387923B2 (en) * | 2000-03-22 | 2002-05-14 | Biocryst Pharmacueticals, Inc. | Imminoribitol PNP inhibitors, preparation thereof and use thereof |
WO2002018371A1 (fr) * | 2000-08-29 | 2002-03-07 | Industrial Research Limited | Inhibiteurs du metabolisme des nucleosides |
US20040076809A1 (en) * | 2001-09-13 | 2004-04-22 | Spears Ward R. | Composite flywheel rim having commingled layers with macroscopically uniform patterns of fiber arrangement and methods for manufacturing same |
US6660719B2 (en) * | 2001-12-17 | 2003-12-09 | Biocryst Pharmaceuticals Inc. | Inhibiting T-Cell proliferation |
US7098334B2 (en) * | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
ATE478872T1 (de) * | 2002-03-28 | 2010-09-15 | Ustav Ex Botan Av Cr V V I I O | Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung |
WO2003100009A2 (fr) * | 2002-05-23 | 2003-12-04 | Biocryst Pharmaceuticals, Inc. | Augmentation de l'efficacite d'inhibiteurs de la transcriptase inverse et d'adn polymerase (analogues de nucleoside) a l'aide d'inhibiteurs de pnp et/ou de 2'-deoxyguanosine et/ou d'un promedicament de ceux-ci |
SI1539783T1 (sl) * | 2002-08-21 | 2011-08-31 | Einstein Coll Med | Inhibitorji nukleozidnih fosforilaz in nukleozidaz |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
CA2518791A1 (fr) * | 2003-03-11 | 2004-09-23 | Qlt Usa Inc. | Preparations d'agents anti-cancereux dependant du programme cellulaire |
US6972331B2 (en) * | 2003-04-23 | 2005-12-06 | Biocryst Pharmaceuticals, Inc. | Carboxy pyrrole, process of preparing and use as precursor |
TW200519116A (en) * | 2003-08-26 | 2005-06-16 | Teijin Pharma Ltd | Pyrrolopyrimidine derivatives |
US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
CA2596142A1 (fr) * | 2005-02-04 | 2006-08-10 | Uti Limited Partnership | Analogues nucleosidiques puriques |
WO2007016291A2 (fr) * | 2005-07-27 | 2007-02-08 | Albert Einstein College Of Medicine Of Yeshiva University | Structure de l'etat de transition de 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
US8394950B2 (en) * | 2006-02-22 | 2013-03-12 | Industrial Research Limited | Analogues of coformycin and their use for treating protozoan parasite infections |
EP1991230A4 (fr) * | 2006-02-24 | 2010-12-15 | Einstein Coll Med | Méthodes de traitement du cancer |
WO2007097648A1 (fr) * | 2006-02-24 | 2007-08-30 | Industrial Research Limited | Méthodes de traitement de maladies en utilisant des inhibiteurs de nucléoside phosphorylases et de nucléosidases |
CN101094080B (zh) * | 2006-06-22 | 2012-06-20 | 华为技术有限公司 | 一种即按即通系统中的计费方法 |
US8383636B2 (en) * | 2006-09-07 | 2013-02-26 | Industrial Research Limited | Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
PL2057165T3 (pl) | 2006-09-07 | 2011-08-31 | Victoria Link Ltd | Acykliczne inhibitory aminowe fosforylaz i hydrolaz nukleozydowych |
PT2114925E (pt) * | 2006-12-22 | 2012-05-29 | Einstein Coll Med | Análogos de azetidina de inibidores de nucleosidase e fosforilase |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
CN102014957B (zh) | 2008-04-21 | 2014-12-10 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物 |
US8784870B2 (en) * | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
UA103195C2 (uk) | 2008-08-11 | 2013-09-25 | Глаксосмитклайн Ллк | Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань |
US20110190265A1 (en) * | 2008-09-22 | 2011-08-04 | Schramm Vern L | Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
DK2454263T3 (en) | 2009-07-17 | 2018-10-01 | Albert Einstein College Medicine Inc | 3-HYDROXYPYRROLIDE INHIBITORS OF 5'-METHYLTHIOADENOSINE PHOSPHORYLASE AND - NUCLEOSIDASE |
MX348759B (es) | 2010-10-15 | 2017-06-28 | Biocryst Pharm Inc | Metodos y composiciones para inhibicion de polimerasa. |
US9290501B2 (en) * | 2010-11-29 | 2016-03-22 | Albert Einstein College Of Medicine, Inc. | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
JP2014505705A (ja) | 2011-02-02 | 2014-03-06 | ザ トラスティーズ オブ プリンストン ユニヴァシティ | ウイルス生成モジュレーターとしてのサーチュインモジュレーター |
WO2013014052A1 (fr) | 2011-07-22 | 2013-01-31 | Glaxosmithkline Llc | Composition |
WO2013149258A2 (fr) | 2012-03-30 | 2013-10-03 | Charles Drew University of Medicine and Science | Compositions et procédés de traitement ou de prévention de troubles du syndrome métabolique |
AR090699A1 (es) * | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
JP6063571B2 (ja) | 2012-08-07 | 2017-01-18 | アルバート アインシュタイン カレッジ オブ メディシン,インコーポレイティド | ヘリコバクター・ピロリ感染の治療 |
AR092198A1 (es) | 2012-08-24 | 2015-04-08 | Glaxosmithkline Llc | Derivados de pirazolopirimidinas |
NZ707319A (en) * | 2012-11-20 | 2019-09-27 | Glaxosmithkline Llc | 5h-pyrrolo[3,2-d]pyrimidin-4-amine compounds and their use in the treatment of allergic diseases and other inflammatory conditions |
JP6216387B2 (ja) * | 2012-11-20 | 2017-10-18 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC | 新規化合物 |
AU2013348216B2 (en) * | 2012-11-20 | 2016-10-13 | Glaxosmithkline Llc | Novel compounds |
ES2499965B2 (es) * | 2013-03-27 | 2015-03-31 | Universidad De Alicante | Procedimiento de síntesis de compuestos homólogos de azanucleósidos |
US9616129B2 (en) | 2013-06-22 | 2017-04-11 | Nitor Therapeutics | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency |
EP3104707B1 (fr) | 2014-02-12 | 2020-07-15 | Albert Einstein College of Medicine, Inc. | Traitement d'infections dues à h pylori à l'aide d'inhibiteurs de la mtan |
CA2973152A1 (fr) * | 2015-01-07 | 2016-07-14 | Euro-Celtique S.A. | Procede de fabrication de forodesine |
MA43812A (fr) | 2016-03-06 | 2018-11-28 | Biocryst Pharm Inc | Procédés et compositions pour le traitement d'une infection par le virus zika |
KR20190024983A (ko) | 2016-06-29 | 2019-03-08 | 오토노미, 인코포레이티드 | 트리글리세라이드 귀 제제 및 이의 용도 |
US20220054494A1 (en) | 2019-03-13 | 2022-02-24 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for treating bladder and urethra dysfunction and disease |
WO2023022216A1 (fr) | 2021-08-20 | 2023-02-23 | 塩野義製薬株式会社 | Dérivés nucléosidiques et leurs promédicaments ayant une action inhibitrice de la croissance virale |
GB202218782D0 (en) | 2022-12-13 | 2023-01-25 | Mehrling Thomas | Purine nucleoside phosphorylase inhibitor for metabolic syndrome |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4711955A (en) * | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
CA2071510C (fr) * | 1989-10-24 | 2004-07-06 | Chris A. Buhr | Oligonucleotides modifies en 2' |
US5506351A (en) * | 1992-07-23 | 1996-04-09 | Isis Pharmaceuticals | Process for the preparation of 2'-O-alkyl guanosine and related compounds |
US5223618A (en) * | 1990-08-13 | 1993-06-29 | Isis Pharmaceuticals, Inc. | 4'-desmethyl nucleoside analog compounds |
AU1739097A (en) * | 1996-02-23 | 1997-09-10 | Albert Einstein College Of Medicine Of Yeshiva University | Enzyme detection/assay method and substrates |
US5985848A (en) * | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
US7022677B1 (en) * | 1999-02-18 | 2006-04-04 | Kaken Pharmaceutical Co., Ltd. | Amide derivatives as growth hormone secretagogues |
ES2625636T3 (es) * | 1999-04-08 | 2017-07-20 | Victoria Link Limited | Proceso para preparar inhibidores del metabolismo de nucleósidos |
US6448799B1 (en) * | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester |
WO2002018371A1 (fr) * | 2000-08-29 | 2002-03-07 | Industrial Research Limited | Inhibiteurs du metabolisme des nucleosides |
US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof |
US7098334B2 (en) | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
SI1539783T1 (sl) | 2002-08-21 | 2011-08-31 | Einstein Coll Med | Inhibitorji nukleozidnih fosforilaz in nukleozidaz |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
EP1771452A4 (fr) | 2004-07-27 | 2009-07-15 | Biocryst Pharm Inc | Inhibiteurs de 5'-methylthioadenosine phosphorylase et 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
NZ540160A (en) | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
WO2007097648A1 (fr) | 2006-02-24 | 2007-08-30 | Industrial Research Limited | Méthodes de traitement de maladies en utilisant des inhibiteurs de nucléoside phosphorylases et de nucléosidases |
EP1991230A4 (fr) | 2006-02-24 | 2010-12-15 | Einstein Coll Med | Méthodes de traitement du cancer |
-
1997
- 1997-10-14 US US08/949,388 patent/US5985848A/en not_active Expired - Lifetime
-
1998
- 1998-10-14 WO PCT/US1998/021717 patent/WO1999019338A1/fr active IP Right Grant
- 1998-10-14 AU AU10866/99A patent/AU749098B2/en not_active Expired
- 1998-10-14 PT PT98953516T patent/PT1023308E/pt unknown
- 1998-10-14 EP EP98953516A patent/EP1023308B1/fr not_active Expired - Lifetime
- 1998-10-14 AT AT98953516T patent/ATE304019T1/de active
- 1998-10-14 KR KR1020007003944A patent/KR100637479B1/ko not_active IP Right Cessation
- 1998-10-14 DE DE69831499T patent/DE69831499T2/de not_active Expired - Lifetime
- 1998-10-14 DK DK98953516T patent/DK1023308T3/da active
- 1998-10-14 CN CNB988114895A patent/CN1220695C/zh not_active Expired - Lifetime
- 1998-10-14 US US09/172,321 patent/US6066722A/en not_active Expired - Lifetime
- 1998-10-14 JP JP2000515909A patent/JP4451983B2/ja not_active Expired - Lifetime
- 1998-10-14 ES ES98953516T patent/ES2249844T3/es not_active Expired - Lifetime
- 1998-10-14 CA CA002305760A patent/CA2305760C/fr not_active Expired - Lifetime
- 1998-10-14 CN CNB2005100920669A patent/CN100393722C/zh not_active Expired - Lifetime
-
2000
- 2000-02-03 US US09/496,741 patent/US6228847B1/en not_active Expired - Lifetime
-
2001
- 2001-03-28 US US09/820,276 patent/US6492347B2/en not_active Expired - Lifetime
-
2002
- 2002-10-10 US US10/268,652 patent/US6803455B2/en not_active Expired - Lifetime
-
2004
- 2004-09-02 US US10/932,841 patent/US7211653B2/en not_active Expired - Fee Related
-
2006
- 2006-08-25 HK HK06109456A patent/HK1089159A1/xx not_active IP Right Cessation
-
2007
- 2007-03-26 US US11/728,730 patent/US7390890B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100393722C (zh) | 2008-06-11 |
CN1279686A (zh) | 2001-01-10 |
US6066722A (en) | 2000-05-23 |
US20050026936A1 (en) | 2005-02-03 |
AU749098B2 (en) | 2002-06-20 |
US20030096830A1 (en) | 2003-05-22 |
US6492347B2 (en) | 2002-12-10 |
CN1220695C (zh) | 2005-09-28 |
US5985848A (en) | 1999-11-16 |
US7211653B2 (en) | 2007-05-01 |
ES2249844T3 (es) | 2006-04-01 |
DE69831499D1 (de) | 2005-10-13 |
EP1023308B1 (fr) | 2005-09-07 |
ATE304019T1 (de) | 2005-09-15 |
AU1086699A (en) | 1999-05-03 |
US7390890B2 (en) | 2008-06-24 |
PT1023308E (pt) | 2005-11-30 |
US6803455B2 (en) | 2004-10-12 |
WO1999019338A1 (fr) | 1999-04-22 |
DE69831499T2 (de) | 2006-06-14 |
DK1023308T3 (da) | 2006-01-23 |
KR100637479B1 (ko) | 2006-10-20 |
CA2305760C (fr) | 2008-06-03 |
EP1023308A1 (fr) | 2000-08-02 |
EP1023308A4 (fr) | 2002-05-29 |
KR20010031082A (ko) | 2001-04-16 |
CA2305760A1 (fr) | 1999-04-22 |
JP2001519437A (ja) | 2001-10-23 |
US6228847B1 (en) | 2001-05-08 |
CN1757646A (zh) | 2006-04-12 |
US20020061898A1 (en) | 2002-05-23 |
JP4451983B2 (ja) | 2010-04-14 |
US20070197561A1 (en) | 2007-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1089159A1 (en) | Inhibitors of nucleoside metabolism | |
EP2308845A3 (fr) | Inhibiteurs de caspases et leur utilisation | |
ZA976705B (en) | Process for the synthesis of protected esters of (S)-3,4-dihydroxybutric acid. | |
IL133891A0 (en) | 2-valproenoic acid amide derivatives, their preparation and pharmaceutical compositions containing them | |
WO2001009103A3 (fr) | Agents antiproliferatifs imidazole | |
HUP0102471A2 (hu) | 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények | |
MXPA01011517A (es) | Nucleosidos de 4'-c-etinil-purina. | |
TW360652B (en) | Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them | |
NZ332923A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
TW252979B (fr) | ||
AP1518A (en) | Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds. | |
CA2266565A1 (fr) | Inhibiteurs de rotomase azabicycliques | |
YU28902A (sh) | Fenil- i piridil-tetrahidro-piridini koji imaju tnf-inhibitorsku aktivnost | |
ES2128960A1 (es) | Derivados de fluorofenil-triazinas y pirimidinas compuestos farmacologicamente activos en el sistema nervioso central. | |
IL148590A0 (en) | Alkaloid compounds and pharmaceutical compositions containing the same | |
ES2006336A6 (es) | Procedimiento de preparacion de nuevas acetamidas derivadas de la 2,3-dihidro-3-fenil-2-benzofuranona. | |
ES8608467A1 (es) | Procedimiento de preparacion de un derivado 1,1-difenilpro- pan-1-ol | |
ES8605819A1 (es) | Procedimiento de preparacion de nuevos derivados nucleosidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20181013 |